Related Experiment Videos
A new treatment for high grade gliomas of the brain
1Department of Radiation Oncology, Allegheny University of the Health Sciences Allegheny University Hospitals, Hahnemann, Philadelphia, USA.
Bulletin Et Memoires De L'Academie Royale De Medecine De Belgique
|February 16, 1999
Abstract:
The data confirmed the fact that repeated administrations of iodine-125 labeled anti-epidermal growth factor receptor 425 is safe and may have benefited the management of primary high grade gliomas of the brain as well as recurrent astrocytomas. At present, a randomized control phase III trial is in the process of being initiated to evaluate the benefits that would accrue in a controlled environment.